NCT01241539View on ClinicalTrials.gov

Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Conditions
Cardiovascular DiseasesKidney Failure, Chronic
Interventions
DRUG

Dabigatran etexilate

150 mg capsule

DRUG

Dabigatran etexilate

75 mg capsule

DRUG

Dabigatran etexilate

110 mg capsule

Trial Locations (1)

Unknown

1160.121.1 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY